BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho H, Shin I, Cho K, Yoon H, Yoo EK, Kim M, Park S, Lee I, Kim ND, Sim T. Identification of Novel Resorcinol Amide Derivatives as Potent and Specific Pyruvate Dehydrogenase Kinase (PDHK) Inhibitors. J Med Chem 2019;62:8461-79. [DOI: 10.1021/acs.jmedchem.9b00565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Anwar S, Shamsi A, Mohammad T, Islam A, Hassan MI. Targeting pyruvate dehydrogenase kinase signaling in the development of effective cancer therapy. Biochim Biophys Acta Rev Cancer 2021;1876:188568. [PMID: 34023419 DOI: 10.1016/j.bbcan.2021.188568] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Ghinet A, Thuru X, Floquet E, Dubois J, Farce A, Rigo B. Enhanced antitumor potential induced by chloroacetate-loaded benzophenones acting as fused tubulin-pyruvate dehydrogenase kinase 1 (PDHK1) ligands. Bioorganic Chemistry 2020;96:103643. [DOI: 10.1016/j.bioorg.2020.103643] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Kwak CH, Jin L, Han JH, Han CW, Kim E, Cho M, Chung TW, Bae SJ, Jang SB, Ha KT. Ilimaquinone Induces the Apoptotic Cell Death of Cancer Cells by Reducing Pyruvate Dehydrogenase Kinase 1 Activity. Int J Mol Sci 2020;21:E6021. [PMID: 32825675 DOI: 10.3390/ijms21176021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]